Showing results (2301-2310 of 6,777) with videos related to

Sort By:
Pageof 678
Clinical Therapeutics|March 1, 2011
Efficacy of standard doses of Ibuprofen alone, alternating, and combined with acetaminophen for the treatment of febrile childrenIan M Paul, Sarah A Sturgis, Chengwu Yang, et al.
Clinical Therapeutics|March 1, 2011
Economic analysis of decitabine versus best supportive care in the treatment of intermediate- and high-risk myelodysplastic syndromes from a US payer perspectiveFeng Pan, Siyang Peng, Rachael Fleurence, et al.
Clinical Therapeutics|March 1, 2011
Prevalence, cumulative incidence, monotherapy and combination therapy, and treatment duration of frequently prescribed psychoactive medications in the Netherlands: retrospective database analysis for the years 2000 to 2005Silvia Ravera, Sipke T Visser, Johan J de Gier, et al.
Clinical Therapeutics|July 1, 1990
Selegiline versus L-acetylcarnitine in the treatment of Alzheimer-type dementiaN Campi, G P Todeschini, L Scarzella
Clinical Therapeutics|July 5, 2011
Repeated and escalating preoperative subanesthetic doses of ketamine for postoperative pain control in patients undergoing tumor resection: a randomized, placebo-controlled, double-blind trialEvgeny Rakhman, Dmitri Shmain, Ian White, et al.
Clinical Therapeutics|July 5, 2011
Pharmacokinetics of oral cyanocobalamin formulated with sodium N-[8-(2-hydroxybenzoyl)amino]caprylate (SNAC): an open-label, randomized, single-dose, parallel-group study in healthy male subjectsM Cristina Castelli, Diane F Wong, Kristen Friedman, et al.
Clinical Therapeutics|July 12, 2011
Review of the therapeutic uses of liraglutideGina J Ryan, Karla T Foster, Lynetta Johnson Jobe
Clinical Therapeutics|March 24, 2007
The history and contemporary challenges of the US Food and Drug AdministrationAndrea T Borchers, Frank Hagie, Carl L Keen, et al.
Clinical Therapeutics|March 24, 2007
Pregabalin: a novel gamma-aminobutyric acid analogue in the treatment of neuropathic pain, partial-onset seizures, and anxiety disordersDaniel M Tassone, Eric Boyce, Jennifer Guyer, et al.
Clinical Therapeutics|March 24, 2007
Comparison of valsartan/hydrochlorothiazide combination therapy at doses up to 320/25 mg versus monotherapy: a double-blind, placebo-controlled study followed by long-term combination therapy in hypertensive adultsJames L Pool, Robert Glazer, Myron Weinberger, et al.
Pageof 678